CASI Pharmaceuticals (CASI) Ownership - Who owns CASI Pharmaceuticals?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

No. 81, Jianguo Road

Phone

+86 01065618789

Employees

243

Web

https://www.casipharmaceuticals.com

Details

Group

Domestic Stock Funds

Fundamentals

CASI

Capitalization

100M

P/E Ratio

N/A

Risk (Beta)

1.34

Dividend Yield

N/A

Total Cash

12.7M

Total Cash/Share

0.82

Total Debt

18.5M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

1.72%

Revenue

23.1M

ROE

N/A

Book Value

9.02M

P/B Ratio

11.14

Cash Flow

N/A

Earnings

-2.03

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

3.88

Current Revenue Per Employee

16374.49

Dividends Per Share - Security

N/A

EBITDA

-27.48M

Float

N/A

Float - Current

N/A

Gross Income Margin

51.95

Revenue To Assets

-42.13

Shares Held By Institutions

1.73M

Shares Outstanding - Current

15.5M

Total Liabilities

42.2M

Total Volume MTD

N/A

Value

-1

Gain YTD

-12.570

View a ticker or compare two or three

Compare

CASI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CASI
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CASI (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical drugs for treating cancer and inflammatory diseases

Industry Biotechnology